| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 1,907 | 0.00 | 108,132 |
| 1 Oct 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 2,229 | 0.00 | 106,225 |
| 1 Jul 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 1,843 | 0.00 | 103,996 |
| 3 Jun 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 13,097 | 0.00 | 102,153 |
| 3 Jun 24 | RXRX Recursion Pharmaceuticals | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 8.59 | 26,193 | 225.00 k | 26,193 |
| 1 Apr 24 | RXRX Recursion Pharmaceuticals | Class A Common Stock | Grant | Acquire A | No | No | 0 | 1,467 | 0.00 | 89,056 |
